---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-013467"
form_type: "8-K"
ticker: "ABBV"
cik: "0001551152"
company_name: "AbbVie Inc."
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:09:24.298085+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# AbbVie appoints CEO Robert Michael as Chairman, Gonzalez to retire July 1, 2025

## Summary
- CEO Robert A. Michael unanimously elected Chairman, effective July 1, 2025.
- Chairman Richard A. Gonzalez retires from board effective July 1, 2025; served as Chairman since AbbVie's 2013 formation.
- Director Glenn F. Tilton also retires from board effective July 1, 2025; lead independent director from 2013 to 2024.
- Michael continues as CEO and assumes additional role of Chairman.

## SEC filing metadata
- accession: 0001104659-25-013467
- form_type: 8-K
- ticker: ABBV
- cik: 0001551152
- company_name: AbbVie Inc.
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/0001104659-25-013467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/tm256372d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-013467
- JSON: https://secwatch.observer/filing/0001104659-25-013467.json
- Plain text: https://secwatch.observer/filing/0001104659-25-013467.txt

## Key facts
- Executive change
  Glenn F. Tilton departed as Director at AbbVie Inc..
  - Action: retire
  - Role: Director
  source text: Glenn F. Tilton informed the Company of his decision to retire as a director, effective July 1, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/0001104659-25-013467-index.htm
- Executive change
  Richard A. Gonzalez departed as Chairman at AbbVie Inc..
  - Action: retire
  - Role: Chairman
  source text: Mr. Gonzalez, who has served as Chairman since the Company’s formation in 2013, will retire from the Board, effective July 1, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/0001104659-25-013467-index.htm
- Executive change
  Robert A. Michael was elected as Chairman of the Board at AbbVie Inc..
  - Action: elected
  - Role: Chairman of the Board
  source text: On February 13, 2025, the Board of Directors (the “Board”) of AbbVie Inc. (the “Company”) unanimously elected Robert A. Michael to succeed Richard A. Gonzalez as the Company’s Chairman, effective July 1, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/0001104659-25-013467-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.